AIM IMMUNOTECH INC. Other Asset Impairment Charges
AIM IMMUNOTECH INC. (AIM) reported Other Asset Impairment Charges of $1.80 million for the 12-month period ending 2021-12-31, per its 10-K filed 2024-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2024-04-01
- AIM IMMUNOTECH INC. other asset impairment charges for fiscal 2021 was $1.80M, a 1233.33% increase from fiscal 2020.
- AIM IMMUNOTECH INC. other asset impairment charges for fiscal 2020 was $135.00K.
| Period end | Other Asset Impairment Charges 12 month | Other Asset Impairment Charges 12 month as first filed |
|---|---|---|
| 2021-12-31 | $1.80M 10-K · filed 2024-04-01 | $1.78M 10-K · filed 2022-03-31 |
| 2020-12-31 | $135.00K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |